The increased CSF levels of UCHL1 in patients with ALS may be a marker for increased cellular degeneration and loss of UCHL1 to the extracellular environment similar to models proposed for increased Neurofilament light (NfL) in ALS CSF (Bridel et al. 2019). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.